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The HIV/AIDS epidemic affects virtually every community 
in South Africa. Many people live in rural settings, and 
the Eastern Cape, in which there are a large number 
of rural communities, has an HIV prevalence of 29.5% 
among antenatal clinic attendees.1 Many people are in 
need of antiretroviral drug therapy (ART).  
The Keiskamma AIDS Treatment (KAT) programme 
began in Hamburg, Eastern Cape, in July 2004. It was 
established in response to community needs, identified 
through routine work in the local primary care clinics. 
Both the desperate need for and total absence of ARVs 
in the area were clearly apparent. The KAT programme, 
in partnership with PEPFAR, was the first provider of 
antiretrovirals (ARVs) in the Ngqushwa (Peddie) district. 
Like the Madwaleni Hospital ARV programme featured 
in this journal2 in 2006, the KAT programme serves 
impoverished rural communities. The KAT programme 
differs from Madwaleni in some ways. The KAT programme 
is a community-based service designed to cater for all 
those in need of ARVs. This includes people living with 
HIV/AIDS who are too sick or too poor to access facility-
based resources, in an area where the sparse, rural 
distribution of villages add geographical and logistical 
challenges. The set-up of the KAT programme and the 
manner in which it began functioning closely reflected 
the needs of these patients. 
ARVs have only become widely available in South Africa 
since government funding was made available in 2004.3 
As a result, rural treatment programmes do not yet 
have many patient follow-up results available (scarce 
resources being concentrated on patient care rather 
than data collection and analysis).
This study follows the progress of the first patients 
through the KAT programme. The study period runs 
from July 2004 to February 2006, during which time 174 
adults entered the programme. 
BACKGROUND AND METHODS
The KAT programme is heavily dependent on the local 
communities it serves. Members of these communities 
are employed as nursing staff, caregivers, community 
health workers and drivers. The KAT programme utilises 
their access to local communities as a basis for the 
provision of care. 
The KAT centre opened with the intention of serving 
residents of Hamburg and neighbouring villages. 
Demand for the facility increased rapidly, largely owing 
to lack of alternative facilities in the Ngqushwa district 
(Nompumelelo Hospital in Peddie received limited 
accreditation in March 2006 and full accreditation at 
the end of 2006). Owing to the burden of disease and 
the economic limitations and geographical remoteness 
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of communities, the effective implementation of the 
KAT programme depended on three key components: 
inpatient facilities, transportation, and a network of 
home-based care workers.
The KAT centre was established in an old house in Hamburg, 
a coastal village between East London and Port Alfred 
in the region of the Eastern Cape previously known as 
Ciskei. The house was made available by the Department 
of Public Works. It was equipped with 20 beds and acted 
as a residential facility where patients too ill for ambulant 
care were prepared for and initiated on ARVs according 
to the South African National  Antiretroviral Treatment 
Guidelines.4 Patients would typically stay at the centre 
for 1 - 2 weeks or longer, during which time they would 
be educated about the ARV regimen and the importance 
of adherence. Many of the patients arrived in a very poor 
state of health, extremely weak and unable to care for 
themselves. A benefit of the ‘step-down’ facility meant 
that patients unable to cope at home could be cared for 
and fed in a supportive and secure environment. Patients 
presenting with opportunistic infections were treated 
where possible. Patients left the centre once they were 
prepared and established on their ARV courses. 
The KAT centre uses two bakkies (pick-up trucks) 
with drivers to serve the transportation needs of the 
programme. These fetch and deliver patients and serve 
as ambulances for patients referred to secondary 
and tertiary facilities for specialist consultation. The 
provision of transport by the KAT programme is one 
of its most important elements, as it provides access 
to treatment for patients who are too sick to walk to 
facility-based care or too poor to afford transport. It is 
also an important means by which staff based in the KAT 
centre can interact with the community health worker 
network.
The network of community lay health workers act as 
adherence monitors in the outlying villages and provide 
a means by which patients can contact the KAT centre. 
These carers visit the patients in their homes, and 
maintain regular cellphone contact with the KAT centre. 
There are 19 villages in Peddie South, all of which have 
monitors. The KAT programme aims for 2 monitors 
per village and at the time of this study employed 32 
monitors on stipends. 
The majority of patients are referred to the KAT centre 
by the primary care clinics in the area. However, some 
patients turn up un-referred and patients have arrived 
from as far away as Port Elizabeth, King William’s Town and 
Middle Drift. For patients living beyond the community 
health worker network, adherence monitoring is more 
complicated. These patients travel as a last resort, telling 
stories of past encounters with health care authorities 
that are characterised by frustration, misunderstandings 
and missed opportunities. In response to their acute 
needs and desperation, the KAT programme policy is to 
offer effective and compassionate care for people living 
with HIV and AIDS, regardless of where they live.
A high proportion of patients arrive at the KAT centre very 
sick with concurrent TB. Many had been awaiting sputum 
results at their local health services, and treatment for TB 
frequently resulted in remarkable recoveries in patients 
assumed to be dying of AIDS but who were in fact dying 
from TB. 
For the purpose of this study, which assesses the first 
174 patients seen (between July 2004 and February 
2006), patients were clinically classified as ambulant 
or bedridden, and CD4 count at treatment initiation 
provided a baseline measure. Possible patient outcomes, 
as measured after 6 months of treatment, are ‘good 
response’ (viral load (VL) <400 copies/ml, or if not 
available CD4 count >250 cells/µl), ‘poor response’ (VL 
>400 copies/ml, or CD4 <250 cells/µl), ‘died’, ‘lost to 
follow-up’, ‘insufficient data’ and ‘transferred out’ (gone 
to other ART programmes). 
RESULTS
BASELINE DEMOGRAPHICS
Of the study population, 26% were male and 74% female; 
42% of those who initiated treatment were assessed as 
bedridden, and the remaining 58% were ambulant. 
Baseline CD4 counts are available for 93% of the study 
group. Of these, 37% were in the range 0 - 49 cells/µl, 
26% were 50 - 99 cells/µl, 26% were 100 - 199 cells/µl 
and 11% were in the range ≥200 cells/µl. 
Before the Treatment Centre was acquired, patients needing 
‘inpatient’ care were accommodated in the home of a 
counsellor.
A staff member speaks to patients in the Treatment Centre.
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PATIENT OUTCOMES
Only 2 patients discontinued treatment, one for personal 
reasons and the other because of severe psychotic side-
effects. Twenty-seven patients (16%) were transferred out 
to other ARV programmes. Unless otherwise stated, the 
following figures and discussion relate to the outcomes 
of the 145 patients (83% of the baseline population) for 
whom data are available.
Fig. 1 shows that the majority (61%, N=88) of patients 
had a good response, 16% (N=23) had a poor response, 
21% (N=30) died and 3% (N=4) were lost to follow-up. 
At treatment initiation, 70 patients (41% of the baseline 
population) were bedridden (Table I). Analysis of available 
patient outcomes shows that 43% of the bedridden 
patients died, a considerably higher percentage than 
in the ambulant patients. Of the ambulant population, 
95% survived and nearly three-quarters achieved a good 
response. There were no significant differences between 
male and female patients in either group.
DISCUSSION
In addition to more women living in rural areas and 
higher infection rates in women,5 the significantly larger 
number of female participants may reflect difficulties 
in accessing male patients. The distribution of baseline 
CD4 counts in this population differs from what may 
be considered ideal for ARV programme initiates. The 
majority of patients presented with critically low CD4 
counts. 
The CD4 count distribution seen in this population is 
likely to have arisen for two principal reasons. As this 
was the first service to provide ARV treatment in the 
area, a reservoir of seriously ill patients with advanced 
disease progression and low CD4 counts would have 
existed. Additionally, the nature of the KAT programme 
is likely to have meant that more patients with lower 
CD4 counts were included than would be found 
in conventional facility-based programmes. Using 
information provided by community members, the KAT 
programme actively seeks persons in need of ARVs. 
This facilitated treatment for patients unable to access 
facility-based care. Of patients with baseline CD4 counts 
0 - 99 cells/µl, 56% were bedridden and unlikely to have 
accessed conventional facility-based care.
Because the treatment centre is recently established, it is 
important to review patient outcomes. It is encouraging 
that 80% of the study population survived or were 
transferred out. With time it is hoped the KAT programme 
will pick up patients earlier, when their CD4 levels are 
closer to 200 cells/µl. 
The fact that 98% of all patients who entered the 
programme were successfully followed up may be 
attributed to the community-based system the KAT 
programme operates. The training and involvement of 
community health workers appears to be a successful 
policy. The benefits of this system include the monitors’ 
intimate knowledge of local people and communities, their 
ability to communicate effectively, close geographical 
proximity to patients, and an understanding of patient 
cultural backgrounds. These factors will have had an 
important role in achieving the low number of patients 
lost to follow-up.
Although considerably more bedridden patients than 
ambulant patients in the programme died, outcomes 
in the former group can still be regarded as highly 
successful. These moribund patients were extremely 
ill at treatment initiation. It should also be noted that 
the majority of bedridden patients who died did so 




Total population (N=172) 102 (59%) 70 (41%)
Data available (N=145) 84 (58%) 61 (42%)
Good response 61 (73%) 27 (44%)
Poor response 17 (20%) 6 (10%)
Lost to follow-up 2 (2%) 2 (3%)
Died 3 (5%) 24 (43%)
TABLE I. BREAKDOwN Of AvAILABLE PATIENT 
OUTCOMES By BASELINE CLINICAL STATUS AT 
TREATMENT INITIATION
Fig. 1. Breakdown of known patient outcomes by baseline CD4 
group in 145 patients.
A health education session at the Treatment Centre.
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CONCLUSIONS AND IMPLICATIONS
The results of this study suggest that the KAT programme 
achieved some notable successes in its first period of 
operation, July 2004 - February 2006. The unconventional, 
community-based, bottom-up approach appears to be 
well suited to the area and people it serves. Patients 
in preparation for treatment initiation experienced the 
benefits of the ‘step-down’ inpatient facility which 
brought them to a level of health where ARV initiation 
was viable. The inpatient centre also acted as an effective 
platform on which ARV counselling and education could 
be conducted. The patient outcomes suggest that key 
issues such as regimen understanding and adherence 
were successfully addressed. The transport system 
used by the KAT programme made it possible for the 
programme to be accessed by those most in need – the 
sickest and poorest.
Community health workers were key to the success of 
the KAT programme. They provided an extensive support 
network throughout the district. The high adherence and 
low proportion of patients lost to follow-up are successes 
attributable to these workers. Community health workers 
are also important sources of useful related local 
information, such as identifying other persons in need of 
help within their communities. Effective communication 
and co-operation between community health workers 
and the KAT centre has been crucial.
Community involvement made it possible to access 
bedridden patients otherwise not visible to health 
services. It is likely that the vast majority of these patients 
would have died had the KAT programme operated a 
conventional facility-based service. This study provides 
evidence that no one should be regarded as too sick to 
enter treatment programmes, and effort and resources 
should be expended in order to include such patients 
into a treatment programme.  
This study provides evidence that a community-based 
model of ARV distribution can be effective in rural 
settings. At the time of writing, the KAT programme was 
integrating with recently accredited government ARV 
providers in the district, but continued to fill the gaps 
where patients are unable to access government services. 
Working within the government HIV/ARV programme is 
important for sustainability. This must not be done at the 
cost of care provision to rural communities. The potential 
for community-based ARV programmes to substantially 
improve rural health care exists. It is important that such 
programmes play a role in national HIV/ARV policy. 
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An essential part of the programme is home visits.
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